<DOC>
	<DOCNO>NCT02085876</DOCNO>
	<brief_summary>This single centre prospective open-label , non-randomised pilot study whose aim identify MRI parameter well evaluate inflammation liver fibrosis thus , near future , avoid need liver biopsy . To achieve : - The MRI study complete add two sequence : Measurement T1 multiecho T2* . The data extract usual sequence . - Part histological sample use weighted level fat iron , lipidomic study . - Usual blood sample complete sample serum library</brief_summary>
	<brief_title>Quantitative Qualitative MRI Study Steatosis Patients With Metabolic Steatopathy</brief_title>
	<detailed_description />
	<mesh_term>Overweight</mesh_term>
	<criteria>Patients inform research Patients national health insurance cover Patients overweight ( BMI &gt; 25 ) type 2 diabetes suggest disturbance hepatic enzyme ( ASAT &lt; 8 time normal value ALAT &gt; twice normal value ) complete hepatopathy assessment Obese patient hepatic anomaly ( steatosis ) reveal image biological assessment ( ASAT &lt; 8 time normal value ALAT &gt; twice normal value ) eligible bariatric surgery preoperative liver MRI examination . Noncorrected coagulation disorder . Patients age 80 year Patients age less 18 year Patients without legal protection Patients contraindication MRI ( Pacemaker , intraocular metallic foreign body , weight &gt; 150kg ) Patients without national health insurance cover</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>patient</keyword>
	<keyword>present</keyword>
	<keyword>undergo bariatric surgery</keyword>
</DOC>